Trial Profile
A Multicenter, Open Label, Pilot Study of MK-5172 (Grazoprevir)/MK-8742 (Elbasvir) Without Ribavirin for 12 Weeks in G1b and G4 Patients With HCV-related Cryoglobulinemic Nephropathy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2020
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms CRYOKID
- 15 Feb 2018 New trial record